Direkt zum Inhalt
Merck

Dynamic proteomic and phosphoproteomic atlas of corticostriatal axons in neurodevelopment.

eLife (2022-10-15)
Vasin Dumrongprechachan, Ryan B Salisbury, Lindsey Butler, Matthew L MacDonald, Yevgenia Kozorovitskiy
ZUSAMMENFASSUNG

Mammalian axonal development begins in embryonic stages and continues postnatally. After birth, axonal proteomic landscape changes rapidly, coordinated by transcription, protein turnover, and post-translational modifications. Comprehensive profiling of axonal proteomes across neurodevelopment is limited, with most studies lacking cell-type and neural circuit specificity, resulting in substantial information loss. We create a Cre-dependent APEX2 reporter mouse line and map cell-type-specific proteome of corticostriatal projections across postnatal development. We synthesize analysis frameworks to define temporal patterns of axonal proteome and phosphoproteome, identifying co-regulated proteins and phosphorylations associated with genetic risk for human brain disorders. We discover proline-directed kinases as major developmental regulators. APEX2 transgenic reporter proximity labeling offers flexible strategies for subcellular proteomics with cell type specificity in early neurodevelopment, a critical period for neuropsychiatric disease.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Anti-Tyrosin-Hydroxylase-Antikörper, Chemicon®, from rabbit
Sigma-Aldrich
eSpCas9-Protein, from Streptococcus pyogenes with mutations conferring enhanced specificity, recombinant, expressed in E. coli, 1X NLS